CASSAUNDRA LEWIS: Open Payments
NPI 1730649559 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,129 in 110 payments from 19 companies in 2025. Trend: 2023 $876 · 2024 $3,014 · 2025 $2,129
Food & beverage: $2,129
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $284 |
| ABBVIE INC. | 7 | $198 |
| Axsome Therapeutics, Inc. | 9 | $195 |
| Vanda Pharmaceuticals Inc. | 11 | $187 |
| E.R. Squibb & Sons, L.L.C. | 9 | $181 |
| Supernus Pharmaceuticals, Inc. | 13 | $177 |
| Alkermes, Inc. | 9 | $160 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $156 |
| Tris Pharma Inc | 9 | $135 |
| Janssen Pharmaceuticals, Inc | 5 | $134 |
Products named: TRINTELLIX, VRAYLAR, Auvelity, COBENFY, Qelbree, CAPLYTA, HETLIOZ, Dyanavel XR.
Industry payments across FL — which companies pay providers there.
